Back to search

University of Thessaly (UTH)

Σχέση αντιφωσφολιπιδικών αντισωμάτων και αγγειακών επιπλοκών στους αιμοκαθαιρόμενους διαβητικούς ασθενείς

Abstract

dc:description

The dysfunction of arteriovenous communications of patients requiring hemodialysis is an important factor of excess morbidity and mortality but also of increased health care cost. This phenomenon is observed in accesses made by native vessels (fistulas) and those made with the use of PTFE grafts.In an attempt to explain the phenomenon of thrombosis of arteriovenous communications, we investigated the presence of antiphospholipid antibodies, in particular IgG and IgM antibodies against β2GPI as well as IgG and IgM antibodies against prothrombin, in patients with renal failure and their association with the thrombosis and dysfunction of these communications.The study included 160 patients, divided into 3 groups, diabetic hemodialyzed patients, non-diabetic hemodialyzed patients and non-hemodialyzed diabetic patients with renal failure.Thrombosis of arteriovenous accesses occurred in 42 out of 104 hemodialyzed patients (40.38%). The fistulas appear to thrombose less frequently than grafts (31.76% vs. 91.67%, p=0.0001), both in men and in women. This phenomenon is not related to the presence of diabetes (46.29% for the group of diabetic hemodialyzed patients and 34% for the non-diabetic hemodialyzed ones, p = 0.234). The prevalence of positive antibodies to β2GPI in diabetic hemodialyzed and non-diabetic hemodialyzed subjects does not differ significantly, implying that diabetes mellitus does not have an autoimmune effect at this level.Regarding the quantitative measurement of antiprothrombin antibodies, we found increased levels in the group of non-hemodialyzed patients, compared to the hemodialyzed patients (p=0.045).Our study showed high rates of arteriovenous thrombosis in hemodialyzed patients. The only association of these thromboses found was with the type of arteriovenous communications, without any association with the titre of antiphospholipid antibodies. There is no reason to measure the level of antiphospholipid antibodies in hemodialyzed patients.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Katsaros, Fotios
  • Κατσαρός, Φώτιος

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41233

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Katsaros, Fotios; Κατσαρός, Φώτιος. Σχέση αντιφωσφολιπιδικών αντισωμάτων και αγγειακών επιπλοκών στους αιμοκαθαιρόμενους διαβητικούς ασθενείς. University of Thessaly (UTH), 2017. http://hdl.handle.net/10442/hedi/41233